Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 23ANDME HOLDING CO. (Exact name of registrant as specified in its charter) Delaware 87-1240344 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECU ...

23andMe Holding Co. (NASDAQ:ME) Q1 2023 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Wade Walke - Vice President, Investor Relations Anne Wojcicki - Chief Executive Officer & Co-Founder Steve Schoch - Chief Financial Officer Kenneth Hillan - Chief Therapeutics Officer Conference Call Participants Tiago Fauth - Credit Suisse David Lebowitz - Citi Operator Good morning, and welcome to 23andMe's Fiscal 2023 First Quarter Financial Results Conference Call. As a reminder this call is b ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39587 23ANDME HOLDING CO. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or ...

23andMe Holding Co. (NASDAQ:ME) Q4 2022 Earnings Conference Call May 26, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder and Chief Executive Officer Kenneth Hillan - Chief Therapeutics Officer Steve Schoch - Chief Financial Officer Conference Call Participants Tiago Fauth - Credit Suisse AG Daniel Grosslight - Citigroup Inc. Operator Good morning, and welcome to the 23andMe's Fiscal Year 2022 Fourth Quarter and Year-End Financial Results Conf ...

FORM 10-K Table of Contents (Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO___________ Commission File Number 001-39587 23ANDME HOLDING CO. (Exact name of Registrant as specified in its Charter) Delaware 87-1240344 (State ...

23andMe Holding Co. (NASDAQ:ME) Q3 2022 Earnings Conference Call February 10, 2022 4:30 PM ET Company Participants Wade Walke - Vice President of Investor Relations Anne Wojcicki - Co-Founder & Chief Executive Officer Steve Schoch - Chief Financial Officer Kenneth Hillan - Head of Therapeutics Conference Call Participants Tiago Fauth - Credit Suisse Daniel Grosslight - Citi Operator Good morning and welcome to 23andMe's Fiscal Year 2022 Third Quarter Financial Results Conference Call. As a reminder, this ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39587 23ANDME HOLDING CO. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporatio ...

23andMe Holding Co. (NASDAQ:ME) Q2 2021 Earnings Conference Call November 10, 2021 4:30 PM ET Company Participants Wade Walke - VP, IR Anne Wojcicki - Co-Founder, CEO, President & Director Steven Schoch - Chief Financial & Accounting Officer Kenneth Hillan - Head, Therapeutics Conference Call Participants Daniel Grosslight - Citigroup Operator Good day, ladies and gentlemen, and welcome to the 23andMe's Fiscal Year 2022 Second Quarter Earnings Call. [Operator Instructions]. As a reminder, this conference ca ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39587 23ANDME HOLDING CO. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...

23andMe Holding Co. (NASDAQ:ME) Q1 2022 Earnings Conference Call August 13, 2021 11:00 AM ET Company Participants Wade Walke ??? Vice President-Investor Relations Anne Wojcicki ??? Co-Founder and Chief Executive Officer Steve Schoch ??? Chief Financial Officer Kenneth Hillan ??? Head-Therapeutics Conference Call Participants Daniel Grosslight ??? Citi Operator Good morning, and welcome to 23andMe???s Fiscal Year 2022 First Quarter Financial Results Conference Call. As a reminder, this call is being recorded ...